Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-013334
Filing Date
2023-05-19
Accepted
2023-05-19 16:05:12
Documents
2
Period of Report
2023-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1566
2 EX-24 DOCUMENT attachment1.htm EX-24 3652
  Complete submission text file 0000899243-23-013334.txt   6644
Mailing Address 108 DOCKSIDE CIRCLE WESTON FL 33327
Business Address
Glover Stephen C. (Reporting) CIK: 0001304406 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40505 | Film No.: 23939988

Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma Inc. (Issuer) CIK: 0001836056 (see all company filings)

EIN.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)